InsidersTradesSigma
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
2
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the detailed record of transactions filed by Vickers Philip J., Director. Officer active across 2 companies, notably Revance Therapeutics, Inc.. Aggregated, 5 disclosures have been recorded. Breakdown: 2 buys · 0 sell. Total volume traded: €68k. Activity tracked since 5 May 2021. The latest transaction was disclosed on 4 May 2022 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Declarations5 total
6,059 shares0Common StockSEC:0001479290-22-000064:0
4,800 shares@ US$8.3550.0% of flowCommon StockSEC:0001127602-21-021729
Canonical exit: 5 Oct 2021 (T+90)
4,800 shares@ US$8.3550.0% of flowCommon StockSEC:0001127602-21-021729:0
Canonical exit: 5 Oct 2021 (T+90)
4,013 shares0Common StockSEC:0001479290-21-000116:0
4,013 shares0Common StockSEC:0001479290-21-000116
5 of 5 declarations
About Vickers Philip J.
Philip J. Vickers is a Board Member at Revance Therapeutics, Inc. and AVROBIO, Inc. In this role, he contributes to the governance of these companies, bringing his expertise to the board. Revance Therapeutics is a biopharmaceutical company, while AVROBIO focuses on gene therapy. Mr. Vickers's experience in these sectors is valuable for guiding strategic decisions.
